RADHAKISHAN PHARMACEUTICALS
CYTARINE CYTARABINE INJECTION

CYTARINE CYTARABINE INJECTION

CYTARINE CYTARABINE INJECTION Specification

  • Origin of Medicine
  • Synthetic
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Dosage Form
  • Injection
  • Salt Composition
  • Cytarabine
  • Indication
  • Leukemia, lymphoma
  • Drug Type
  • Allopathic
  • Ingredients
  • Cytarabine
  • Physical Form
  • Injection
  • Function
  • Antineoplastic agent
  • Recommended For
  • Treatment of leukemia and lymphomas
  • Dosage
  • As prescribed by physician
  • Dosage Guidelines
  • Intravenous or subcutaneous administration as directed
  • Suitable For
  • Adults
  • Quantity
  • 1 vial
  • Storage Instructions
  • Store below 25C, protect from light
  • Marketed Country
  • India
  • Pack Size
  • 1 vial/box
  • Route of Administration
  • Intravenous, subcutaneous
  • Therapeutic Class
  • Anticancer
  • Appearance
  • Clear solution
  • Strength
  • 100 mg/ml
  • Contraindications
  • Hypersensitivity to Cytarabine
  • Brand Name
  • Cytarine
  • Use
  • For medical professionals only
  • Side Effects
  • Nausea, vomiting, myelosuppression
  • Prescription Required
  • Yes
  • Shelf Life
  • 24 months
  • Warning
  • For hospital use only
 

CYTARINE CYTARABINE INJECTION Trade Information

  • Packaging Details
  • PACK OF 10 TABLETS
  • Main Domestic Market
  • All India
 

About CYTARINE CYTARABINE INJECTION

Cytarine Injection

Specifications:-

  • Strength:1 g
  • Form:Injection
  • Manufacturer:Fresenus Kabi
  • Brand:CYTARINE
  • Packaging Size:Pack of 10 ml
  • Composition:Cytarabine


Note : - Cytarine Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug................



Indications and Therapeutic Use

Cytarine Cytarabine Injection is indicated as part of the treatment regimen for adult patients diagnosed with leukemia or lymphoma. As an antineoplastic agent, it works by interfering with the multiplication of cancer cells, making it an essential tool in aggressive chemotherapy protocols managed in clinical settings.


Administration and Dosage Guidelines

The injection is administered intravenously or subcutaneously by healthcare professionals, following dosing schedules prescribed by a physician. Dosage may vary based on the patients medical condition and response to treatment, highlighting the importance of personalized care under hospital supervision.


Storage and Handling Precautions

Cytarine must be stored below 25C and protected from light to maintain stability and efficacy. It is intended for hospital use only, ensuring that administration and handling are managed by trained professionals to minimize risk and optimize therapeutic outcomes.

FAQs of CYTARINE CYTARABINE INJECTION:


Q: How should Cytarine Cytarabine Injection be administered?

A: Cytarine should be administered either intravenously or subcutaneously, strictly under the supervision of qualified healthcare professionals in a hospital setting. The dosage and frequency are determined by a physician, based on individual treatment plans.

Q: What are the primary benefits of using Cytarine in cancer therapy?

A: Cytarine is effective in treating leukemia and lymphomas by inhibiting the proliferation of malignant cells. Its targeted mechanism helps manage disease progression when used according to recommended medical guidelines.

Q: When is Cytarine Cytarabine Injection typically prescribed?

A: This injection is prescribed as part of chemotherapy protocols for adults diagnosed with leukemia or lymphomas. It is not intended for preventive or self-initiated therapy and should only be used when prescribed by a specialist.

Q: Where should Cytarine Injection be stored before use?

A: Store Cytarine below 25C, away from direct light, in designated medication storage areas of medical facilities. Proper storage ensures the drug maintains its potency throughout its shelf life.

Q: What side effects may occur with Cytarine administration?

A: Common side effects include nausea, vomiting, and myelosuppression (reduced bone marrow activity). Patients are closely monitored by medical staff for these effects during and after treatment.

Q: Who should not receive Cytarine Cytarabine Injection?

A: This medicine is contraindicated in individuals with known hypersensitivity to cytarabine. It is intended for adults only, and its use should be avoided in individuals where such risks are present.

Q: What is the process for receiving Cytarine Injection?

A: The injection must be obtained and administered in a hospital by medical professionals. The patient will undergo evaluation to determine eligibility and the appropriate dosing schedule for safe and effective treatment.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

X-TRANT ESTRAMUSTINE PHOSPHATE TABLETS

X-TRANT ESTRAMUSTINE PHOSPHATE TABLETS

Minimum Order Quantity : 1 Bottle

Physical Form : Tablets

Dosage : As directed by the physician

Dosage Guidelines : Take with a glass of water, do not crush or chew

Storage Instructions : Store below 25C, protect from light and moisture

Ingredients : Estramustine Phosphate

XBIRA ABIRATERONE ACETATE 250MG TABLETS

XBIRA ABIRATERONE ACETATE 250MG TABLETS

Physical Form : Tablets

Dosage : 250 mg per tablet

Dosage Guidelines : As prescribed by oncologist; typically 1000 mg (4 tablets) once daily on an empty stomach

Storage Instructions : Store below 30C, protect from moisture and light

Ingredients : Abiraterone Acetate

NOVISOF  SOFOSBUVIR TABLETS

NOVISOF SOFOSBUVIR TABLETS

Physical Form : Tablets

Dosage : 400 mg once daily or as directed by physician

Dosage Guidelines : As prescribed by the healthcare professional

Storage Instructions : Store at temperature not exceeding 30C, protected from light and moisture

Ingredients : Sofosbuvir

ERLONAT HYDROCHLORIDE TABLETS

ERLONAT HYDROCHLORIDE TABLETS

Physical Form : Tablets

Dosage Guidelines : Take orally without food, at least 1 hour before or 2 hours after meals, as prescribed

Storage Instructions : Store below 30C, protect from moisture and light

Ingredients : Erlotinib Hydrochloride



Back to top